Karlee Muller, OD Optometrist Medicare: Medicare Enrolled Practice Location: 64 Thompson St Ste B104, East Haven, CT 06513 Phone: 203-469-1012 |
Dr. Maria I Diaz, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 64 Thompson St, Suite B104, East Haven, CT 06513 Phone: 203-469-1012 Fax: 203-467-1369 |
Marc Denigris X, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 135 Saltonstall Pkwy, East Haven, CT 06512 Phone: 203-467-6112 Fax: 203-469-6424 |
East Haven Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 135 Saltonstall Pkwy, East Haven, CT 06512 Phone: 203-265-7990 Fax: 203-265-7998 |
Connecticut Vision Center, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 64 Thompson St, Suite B104, East Haven, CT 06513 Phone: 203-469-1012 Fax: 203-467-1369 |
News Archive
Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that a global agreement was signed with Threshold Pharmaceuticals, Inc., South San Francisco, to co-develop and commercialize TH-302, Threshold's small molecule hypoxia-targeted drug.
Allegro Ophthalmics, LLC, a company dedicated to establishing Integrin Peptide Therapy as the next-generation pharmaceutical category for the treatment of vascular eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application to begin two Phase II clinical studies of ALG-1001.
Results of a new study demonstrated that initial combination therapy with Welchol® (colesevelam HCl) 3.75 g/d and metformin (initiated at 850 mg/d; uptitrated to 1700 mg/d thereafter) significantly improved glycemic and lipid control in drug-naive adult type 2 diabetes patients with high LDL cholesterol (LDL-C).
State agencies, county prosecutors, insurance companies, and health care employers and associations are mandatory reporters — they're required to report potentially dangerous and unprofessional doctors to medical regulators, who can bar the doctors from practicing and keep patients out of harm's way. But the mandatory reporters sound few alarms, and when they do, regulators rarely take action, the Tribune found.
› Verified 7 days ago